DHEA vs DHEA-S: Key Biochemical Differences
DHEA (dehydroepiandrosterone) and DHEA-S (dehydroepiandrosterone sulfate) are distinct forms of the same adrenal androgen precursor, where DHEA-S is the sulfated, more stable form with a longer half-life and serves as the most reliable measure of adrenal androgen production 1.
Fundamental Biochemical Distinctions
DHEA (Dehydroepiandrosterone)
- Active steroid hormone produced primarily in the adrenal cortex
- Shorter half-life and more rapid metabolism
- Serves as the direct precursor for peripheral conversion to testosterone and estrogens 2, 3
- Can be produced in peripheral tissues from DHEA-S through desulfation by steroid sulfatase (STS) 4
- Approximately 74% of DHEA-S is hydrolyzed to DHEA by STS 4
DHEA-S (Dehydroepiandrosterone Sulfate)
- Sulfated metabolite of DHEA, created through sulfation of DHEA
- Much more abundant in circulation than DHEA 2, 5
- Longer half-life and greater stability in serum
- Most reliable measure of adrenal androgen production 1
- Serves as a circulating reservoir that can be converted back to DHEA when needed
Clinical Measurement Implications
When to Measure Each
DHEA-S is the preferred marker for:
- Assessing adrenal androgen production capacity 1
- Evaluating hyperandrogenism in PCOS as a second-line marker (not first-line) 1
- Screening for adrenal tumors (very high levels suggest tumor) 4
- Monitoring adrenal function over time due to stability
Important diagnostic context from 2025 guidelines:
- DHEA-S has poorer specificity (67%) compared to testosterone, calculated free testosterone, or FAI for PCOS diagnosis 1
- Should be considered only when first-line markers (testosterone, calculated free testosterone, FAI) are negative but clinical suspicion remains high 1
- Brings additional costs and risk of overdiagnosis 1
Age-Related Considerations
Critical caveat: DHEA-S levels show marked age variability 1:
- Peak concentrations occur between 20-30 years of age
- Followed by steady gradual decline (termed "adrenopause") 2, 5
- More valuable diagnostically in pre-menopausal than post-menopausal women 1
- High DHEA-S found in 33% of non-classic PCOS patients, with racial variation (20% White, 33% Black patients) 1
Metabolic Interconversion
The relationship between DHEA and DHEA-S involves:
- Bidirectional conversion: DHEA can be sulfated to DHEA-S, and DHEA-S can be desulfated back to DHEA 4
- Enzyme systems: Steroid sulfatase (STS) converts DHEA-S → DHEA; sulfotransferases convert DHEA → DHEA-S 4
- Transport proteins: Both efflux (MRP2, BCRP) and uptake (OATP, OAT) transporters regulate distribution 4
Therapeutic Replacement Context
When DHEA replacement is considered (e.g., primary adrenal insufficiency in women with persistent low libido/energy):
- Oral DHEA tablets (10-50 mg, typically 25 mg daily) are used 6
- Dosing is guided by morning serum DHEA-S, androstenedione, and testosterone levels (measured before DHEA ingestion) 6
- Target: maintain levels in normal range 6
- Limited objective evidence of clinical benefit from large studies; use 6-month trial approach 6
Common Pitfalls to Avoid
Do not use DHEA-S as a first-line marker for PCOS hyperandrogenism—it has inferior specificity compared to testosterone-based measures 1
Do not ignore age when interpreting DHEA-S levels—reference ranges must be age-adjusted 1
Do not assume DHEA and DHEA-S are interchangeable in clinical interpretation—they reflect different aspects of adrenal androgen metabolism 1, 4
Extremely high DHEA-S levels (beyond what's typical for PCOS) should prompt evaluation for adrenal tumor 4